Amicrobe seeks to address the infections that occur whenever our natural barriers are broken. The dramatic rise in antibiotic-resistant bacteria indicates that systemic antibiotics and topical antiseptics are not enough. Amicrobe’s innovative A-Blocks (Amicrobe block copolypeptides) are engineered for broad antimicrobial activity, thorough tissue coverage, and safety in order to prevent and treat life-threatening infections.